Five-Year Study to Enroll 15,000 Adults and Children with NAFLD or NASH NASH Fastest Growing Cause of Liver Cancer and Liver Transplant in the U.S. DUBLIN, April 20, 2017 /PRNewswire/ — Allergan, a leading global biopharmaceutical company, announced today that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on real world evidence, […]
DUBLIN, April 20, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that it has 13 presentations at the upcoming 69th American Academy of Neurology (AAN) annual meeting taking place April 22-28, 2017 in Boston. Among the highlights are three podium presentations on Chronic Migraine disease awareness and post-stroke spasticity […]
AbbVie’s broad commitment to a global effort to cure hepatitis C (HCV) led to a policy, advocacy and awareness initiative called Path to Zero: Fresh Thinking on the Road to Eliminating HCV. April 20, 2017 – The Economist Group’s Path to Zero program, sponsored by AbbVie, aims to foster a global dialogue around innovative solutions […]
Cincinnati, OH – April 19, 2017 – The circular anastomosis is one of the most critical steps in cancer surgery and has a high risk for complications. Complications can include leaks and bleeding which can require reoperation. In an effort to make measurable clinical and cost-of-care improvements for healthcare providers and patients globally, Ethicon*, a […]
Follows regulatory submissions in US, EU and Canada London UK – 18 April 2017 – GSK [LSE/NYSE: GSK] today announced that Japan Vaccine Co., Ltd., a joint venture of GlaxoSmithKline and Daiichi Sankyo Co., Ltd., submitted a New Drug Application in Japan seeking approval for the candidate shingles vaccine, Shingrix, for the prevention of herpes […]
Collaboration Focused on Phase 2b Clinical Trial to Evaluate Use of Allergan’s Cenicriviroc (CVC) and Novartis Lead FXR Agonist to Treat NASH NASH Fastest Growing Cause of Liver Cancer and Liver Transplant in the U.S. DUBLIN, April 18, 2017 /PRNewswire/ — Allergan, a leading global biopharmaceutical company, announced today that it has entered into a […]
ABBOTT PARK, Ill. and WALTHAM, Mass., April 14, 2017 /PRNewswire/ — Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today that the companies have agreed to amend the existing terms of their agreement for Abbott’s acquisition of Alere. Under the amended terms, Abbott will pay $51 per common share to acquire Alere, for a […]
TV Host Wendy Williams Leads the Conversation on the Importance of Bowel Health at the “Vital Signs of Bowel Health” Summit DUBLIN and CAMBRIDGE, Mass., April 13, 2017 /PRNewswire/ — Allergan plc (NYSE:AGN) and Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), in partnership with the American Gastroenterological Association (AGA), initiated a campaign about the importance of bowel health in recognition […]
Campaign educates on the debilitating impact of migraine on patients’ everyday lives DUBLIN, April 11, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN) today unveiled Frames of Mind, an interactive campaign to promote awareness of the impact that migraine can have on patients’ everyday lives. People living with this often debilitating condition are encouraged to submit […]
Company Recognized with ENERGY STAR Award for Sixth Time DUBLIN, April 10, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN) today announced that it has been named a 2017 ENERGY STAR Partner of the Year – Sustained Excellence Award winner. The Company has been recognized for continued leadership in protecting the environment through superior energy efficiency […]